NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
03/17/2026
Back to search
Official data from USPTO
SEQURNA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
18
Latest update
03/17/2026
Trademark type
Combined
Nice classes
1, 5, 10, 42
Filing date
05/23/2025
Registration date
03/17/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/17/2026
Last transaction
03/17/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Foreign priority
Drawing code
3
Owner type
64
Owner location
SOLNA, SE
Examiner
NEPTUNE, EVONNE MARIE
Law office
N90
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of the stylized word "SEQURNA" in all capital letters, wherein the letter "E" is stylized as three horizontal bars in red, green, and orange, and the remaining letters are in the color blue.
Holders and representatives
Holders
SEQURNA AB
Representatives
Charlene Azema Knobbe, Martens, Olson & Bear, LLP
Technical classification
Nice Classes
Class 1Class 5Class 10Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Reagents for medical research; Diagnostic reagents for scientific use; Reagents for research purposes
Class 5
Reagents for medical use; Clinical diagnostic reagents for medical use; Diagnostic reagents for medical use; Reagents for use with analyzers for medical purposes; Diagnostic biomarker reagents for medical purposes; Clinical medical reagents; Reagent paper for medical purposes
Class 10
Medical apparatus and instrumentsvials containing RNase inhibitors used for RNA sequencing; Apparatus for use in medical analysisvials containing RNase inhibitors used for RNA sequencing; Testing apparatus for medical purposes; Diagnostic apparatus for medical purposesvials containing RNase inhibitors used for RNA sequencing; Apparatus for DNA and RNA exams for medical purposes; Capillary tubes for delivering reagents for medical use
Class 42
Scientificmedical and pharmaceutical research and development services; Scientific laboratory services; Medical research laboratory services; Laboratory research services relating to molecular biology and biomedicine; Medical and scientific consulting services in the fields of molecular biology and biomedicine; Providing medical and scientific research information in the field of molecular biology and biomedicine; Pharmaceutical and scientific research and development; Laboratory diagnosticsmedical analysis services relating to the diagnosis and treatment of persons provided by medical laboratories; Informationadvisory and consultancy services relating to the aforesaid
Publications
History of USPTO decisions and trademark events.
18 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
03/17/2026
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/27/2026
PUBO
PUBLISHED FOR OPPOSITION
01/27/2026
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/21/2026
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/02/2026
XAEC
EXAMINER'S AMENDMENT ENTERED
01/02/2026
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
01/02/2026
GNEA
EXAMINERS AMENDMENT E-MAILED
01/02/2026
CNEA
EXAMINERS AMENDMENT -WRITTEN
01/02/2026
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
10/13/2025
GNRT
NON-FINAL ACTION E-MAILED
10/13/2025
CNRT
NON-FINAL ACTION WRITTEN
10/13/2025
DOCK
ASSIGNED TO EXAMINER
10/10/2025
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
10/01/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/01/2025
MAFR
APPLICATION FILING RECEIPT MAILED
05/23/2025
NWAP
NEW APPLICATION ENTERED
05/23/2025
Continuous trademark protection
Get notified about every new filing that threatens SEQURNA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.